Manufacturing Capabilities Labiana operates an EU-GMP certified plant with tablet manufacturing and a capacity of about 20 million units, complemented by Film Coating Technology and seven packaging lines. This enables turnkey contract manufacturing and integrated packaging for scale-focused products.

End to End Development A strong in-house team in Technical, Regulatory Affairs and R&D supports services from concept to production and commercialization, helping clients shorten development timelines and navigate international approvals.

Cross Sector Expertise Labiana serves both human and animal health markets, with activities such as participation in bovine medicine congresses and products like PRECYST, indicating ability to co-develop and manufacture veterinary, human health and nutraceuticals.

Global Market Access With several marketing authorisations worldwide and a regulatory-focused ethos, Labiana can help clients expand internationally by providing regulatory filings and compliant manufacturing across regions.

Financial Momentum Recent financing to refinance debt and fuel growth, along with recognition for sustainable growth and strong 2025 revenue, support Labiana’s credibility as a stable, long-term manufacturing partner.